Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | genetic association 0.31 (overall 0.19) | 0.31 |
| cell type Human Protein Atlas | cell type enhanced, including brain inhibitory neurons; strongest in melanocytes | 0.75 |
| chemistry Open Targets | hard to drug | 0.27 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 2066
Sealed predictions
- LZTS1 in dopamine neurons, braak-0.37 (p 0.323) → -0.36 (p 0.342)receipt 2072
Swarm cases
receipt 2072: LZTS1 in dopamine neurons, braak
- power
- full sample -0.12 (p 0.646, n 18), 95% CI -0.55 to +0.37. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.14 (p 0.585, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.13 (p 0.603, n 18). could be the mix.
- skeptic
- leave-one-out range -0.25 to -0.02, sign flips 0; without severely affected donors -0.12 (p 0.646, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for LZTS1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts